PDF herunterladen
Semin Liver Dis 2003; 23(1): 039-046
DOI: 10.1055/s-2003-37583
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Epidemiology and Prevention of Hepatitis B

Miriam J. Alter
  • Associate Director for Epidemiologic and Public Health Science, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
03. März 2003 (online)

    Lizenzen und Reprints

ABSTRACT

The primary goal of hepatitis B prevention programs is reduction of chronic hepatitis B virus (HBV) infection and HBV-related chronic liver disease. Although donor screening, risk-reduction counseling and services, and effective infection control practices can reduce or eliminate the potential risk for HBV transmission, immunization is by far the single most effective prevention measure. Worldwide, the integration of hepatitis B vaccine into existing childhood vaccination schedules has the greatest likelihood of long-term success. However, by 2000, only 116 of 215 countries had such a policy, representing 31% of the global birth cohort. In addition, efforts must be strengthened to vaccinate older adolescents and adults with high-risk behaviors or occupations in countries where most HBV transmission and the morbidity associated with acute hepatitis B occur among persons in these age groups. Although continued immunization of successive birth cohorts should achieve the eventual elimination of HBV transmission, this will not occur for decades without successful vaccination of adults at increased risk for infection.

KEYWORDS

Hepatitis B - epidemiology - prevention

REFERENCES

  • 1 Kane M. Global programme for control of hepatitis B infection.  Vaccine . 1995;  13(Suppl 1) S47-S49
    PubMedSuche in Google Scholar
  • 2 Beasley R P. Hepatitis B virus. The major etiology of hepatocellular carcinoma.  Cancer . 1988;  61 1942-1956
    PubMedSuche in Google Scholar
  • 3 Alter H J, Purcell R H, Gerin J L. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen.  Infect Immun . 1977;  16 928-933
    PubMedSuche in Google Scholar
  • 4 Bancroft W H, Snitbhan R, Scott R M. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen.  J Infect Dis . 1977;  135 79-85
    PubMedSuche in Google Scholar
  • 5 Alter H J, Seeff L B, Kaplan P M. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.  N Engl J Med . 1976;  295 909-913
    CrossrefPubMedSuche in Google Scholar
  • 6 Hindman S H, Gravelle C R, Murphy B L. "e" antigen, Dane particles and serum DNA polymerase activity in HBsAg carriers.  Ann Intern Med . 1976;  85 458-460
    PubMedSuche in Google Scholar
  • 7 Shikata T, Karasawa T, Abe K. Hepatitis B e antigen and infectivity of hepatitis B virus.  J Infect Dis . 1977;  136 571-576
    CrossrefPubMedSuche in Google Scholar
  • 8 The Incident Investigation Team and Others. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen.  N Engl J Med . 1997;  336 178-184
    CrossrefPubMedSuche in Google Scholar
  • 9 Alter H J, Purcell R H, Holland P V. Clinical and serological analysis of transfusion-associated hepatitis.  Lancet . 1975;  2 838-841
    CrossrefPubMedSuche in Google Scholar
  • 10 Seeff L B, Wright E C, Zimmerman H J. VA cooperative study of post-transfusion hepatitis and responsible risk factors.  Am J Med Sci . 1975;  270 355-362
    PubMedSuche in Google Scholar
  • 11 Hutin Y J, Harpaz R, Drobeniuc J. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova.  Int J Epidemiol . 1999;  28 782-786
    CrossrefPubMedSuche in Google Scholar
  • 12 Alter M J, Ahtone J, Maynard J E. Multiple-dose vial associated with transmission of hepatitis B virus in a hemodialysis unit.  Ann Intern Med . 1983;  99 330-333
    PubMedSuche in Google Scholar
  • 13 Polish L B, Shapiro C N, Bauer F. Nosocomial transmission of hepatitis B virus associated with a spring-loaded fingerstick device.  N Engl J Med . 1992;  326 721-725
    PubMedSuche in Google Scholar
  • 14 Hutin Y J, Goldstein S T, Varma J K. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis.  Infect Control Hosp Epidemiol . 1999;  20 731-735
    PubMedSuche in Google Scholar
  • 15 Drescher J, Wagner D, Haverich A. Nosocomial hepatitis B virus infections in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy.  J Hosp Infect . 1994;  26 81-92
    CrossrefPubMedSuche in Google Scholar
  • 16 Lettau L, McCarthy J G, Smith M H. An outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts.  N Engl J Med . 1987;  317 1256-1261
    PubMedSuche in Google Scholar
  • 17 Mast E E, Alter M J. Prevention of hepatitis B virus infection among health care workers. In: Ellis RS, ed. Hepatitis B Vaccines in Clinical Practice New York: Marcel Dekker 1992: 295-307
    Suche in Google Scholar
  • 18 Limentani A E, Elliott L M. An outbreak of hepatitis B from tattooing.  Lancet . 1979;  2 86-88
    PubMedSuche in Google Scholar
  • 19 Kent G B, Brondum J, Keenlyside R A, LaFazia L M, Scott H D. A large outbreak of acupuncture-associated hepatitis B.  Am J Epidemiol . 1988;  127 591-598
    PubMedSuche in Google Scholar
  • 20 Bond W W, Favero M S, Petersen N J. Survival of hepatitis B virus after drying and storage for one week.  Lancet . 1981;  1 550-551
    PubMedSuche in Google Scholar
  • 21 Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients.  MMWR Recomm Rep . 2001;  50(RR-5) 1-43
    PubMedSuche in Google Scholar
  • 22 Quale J M, Landman D, Wallace B. Déjà vu: nosocomial hepatitis B virus transmission and fingerstick monitoring.  Am J Med . 1998;  105 296-301
    CrossrefPubMedSuche in Google Scholar
  • 23 Douvin C, Simon D, Zinelabidine H. An outbreak of hepatitis B in an endocrinology unit traced to a capillary-blood-sampling device.  N Engl J Med . 1990;  322 57-58
    PubMedSuche in Google Scholar
  • 24 Vickers J, Painter M J, Heptonstall J, Yusaf J HM, Craske J. Hepatitis B outbreak in a drug trials unit: investigation and recommendations.  Commun Dis Rep . 1994;  4 R1-R5
    PubMedSuche in Google Scholar
  • 25 Oren I, Hershow R C, Ben-Porath E. A common-source outbreak of fulminant hepatitis B in a hospital.  Ann Intern Med . 1989;  110 691-698
    PubMedSuche in Google Scholar
  • 26 Dienstag J L, Ryan D M. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization.  Am J Epidemiol . 1982;  115 26-39
    PubMedSuche in Google Scholar
  • 27 Hadler S C, Doto I L, Maynard J E. Occupational risk of hepatitis B infection in hospital workers.  Infect Control . 1985;  6 24-31
    PubMedSuche in Google Scholar
  • 28 Mahoney F J, Stewart K, Hu H. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States.  Arch Intern Med . 1997;  157 2601-2605
    CrossrefPubMedSuche in Google Scholar
  • 29 Carl M, Blakey D L, Francis D P, Maynard J E. Interruption of hepatitis B transmission by modification of a gynaecologist's surgical technique.  Lancet . 1982;  1 731-733
    PubMedSuche in Google Scholar
  • 30 Lettau L A, Smith J D, Williams D. Transmission of hepatitis B with resultant restriction of surgical practice.  JAMA . 1986;  255 934-937
    CrossrefPubMedSuche in Google Scholar
  • 31 Prendergast T J, Teitelbaum S, Peck B. Transmission of hepatitis B by a surgeon [letter].  West J Med . 1991;  154 353
    PubMedSuche in Google Scholar
  • 32 Levin M L, Maddrey W C, Wands J R, Mendeloff A I. Hepatitis B transmission by dentists.  JAMA . 1974;  228 1139-1140
    CrossrefPubMedSuche in Google Scholar
  • 33 Goodwin D, Fannin S T, McCracken B B. An oral-surgeon related hepatitis-B outbreak.  Calif Morbid . 1976;  14 1-2
    PubMedSuche in Google Scholar
  • 34 Rimland D, Parkin W E, Miller G B, Schrack W D. Hepatitis B outbreak traced to an oral surgeon.  N Engl J Med . 1977;  296 953-958
    PubMedSuche in Google Scholar
  • 35 Hadler S C, Sorley D L, Acree K H. An outbreak of hepatitis B in a dental practice.  Ann Intern Med . 1981;  95 133-138
    PubMedSuche in Google Scholar
  • 36 Reingold A L, Kane M A, Murphy B L. Transmission of hepatitis B by an oral surgeon.  J Infect Dis . 1982;  145 262-268
    PubMedSuche in Google Scholar
  • 37 Ahtone J, Goodman R A. Hepatitis B and dental personnel: transmission to patients and prevention issues.  J Am Dent Assoc . 1983;  106 219-222
    PubMedSuche in Google Scholar
  • 38 Goodman R A, Ahtone J L, Finton R J. Hepatitis B transmission from dental personnel to patients: unfinished business [editorial].  Ann Intern Med . 1983;  96 119
    PubMedSuche in Google Scholar
  • 39 Shaw F E, Barrett C L, Hamm R. Lethal outbreak of hepatitis B in a dental practice.  JAMA . 1986;  255 3260-3264
    CrossrefPubMedSuche in Google Scholar
  • 40 CDC. Outbreak of hepatitis B associated with an oral surgeon-New Hampshire.  MMWR Morb Mortal Wkly Rep . 1987;  38 132-133
    PubMedSuche in Google Scholar
  • 41 Public Health Laboratory Service. Acute hepatitis B associated with gynaecological surgery: a report of a collaborative study by the Communicable Disease Surveillance Centre and the Epidemiological Research Laboratory of the Public Health Laboratory Service together with a district control-of-infection service.  Lancet . 1980;  1 595-596
    PubMedSuche in Google Scholar
  • 42 Haerem J W, Siebke J C, Ulstrup J, Geiran O, Helle I. HBsAg transmission from a cardiac surgeon incubating hepatitis B resulting in chronic antigenemia in four patients.  Acta Med Scand . 1981;  210 389-392
    PubMedSuche in Google Scholar
  • 43 District Control of Infection Officer. Acute hepatitis B following gynaecological surgery.  J Hosp Infect . 1987;  9 34-38
    CrossrefPubMedSuche in Google Scholar
  • 44 Coutinho R A, Albrecht-van Lent P, Stoutjesdijk L. Hepatitis B from doctors [letter].  Lancet . 1982;  1 345-346
    PubMedSuche in Google Scholar
  • 45 Polakoff S. Acute hepatitis B in Britain related to previous operations and dental treatment.  Br Med J . 1986;  293 33-36
    PubMedSuche in Google Scholar
  • 46 Welch J, Webster M, Tilzey A J, Noah N D. Hepatitis B infections after gynaecological surgery.  Lancet . 1989;  1 205-207
    PubMedSuche in Google Scholar
  • 47 Polakoff S. Acute viral hepatitis B, reported to the Public Health Laboratory Service.  J Infect . 1990;  20 163-168
    PubMedSuche in Google Scholar
  • 48 Heptonstall J. Outbreaks of hepatitis B virus infection associated with infected surgical staff.  Commun Dis Rep . 1991;  1 R81-R85
    PubMedSuche in Google Scholar
  • 49 Prentice M B, Flower A JE, Morgan G M. Infection with hepatitis B virus after open heart surgery.  Br Med J . 1992;  304 761-764
    PubMedSuche in Google Scholar
  • 50 Johnston B L, MacDonald S, Lee S. Nosocomial hepatitis B associated with orthopedic surgery-Nova Scotia.  Can Commun Dis Rep . 1992;  18 89-90
    PubMedSuche in Google Scholar
  • 51 Snydman D R, Hindman S H, Wineland M D, Bryan J A, Maynard J E. Nosocomial viral hepatitis B: a cluster among staff with subsequent transmission to patients.  Ann Intern Med . 1976;  85 573-577
    PubMedSuche in Google Scholar
  • 52 Grob P J, Bischof B, Naeff F. Cluster of hepatitis B transmitted by a physician.  Lancet . 1981;  2 1218-1220
    PubMedSuche in Google Scholar
  • 53 Johnson I. Hepatitis B-EEG clinics outbreak investigation: final report, January 1997. Ontario Ministry of Health, Toronto, Canada
  • 54 Harpaz R, Von Seidlin L, Averhoff F M. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control.  N Engl J Med . 1996;  334 549-554
    CrossrefPubMedSuche in Google Scholar
  • 55 Spijkerman I JB, van Doorn L-J, Janssen M HW. Transmission of hepatitis B virus from a surgeon to his patients during high-risk low-risk surgical procedures during 4 years.  Infect Control Hosp Epidemiol . 2002;  23 306-312
    CrossrefPubMedSuche in Google Scholar
  • 56 Stevens C E, Neurath R A, Beasley R P. HBeAg and anti-HBs detection by radioimmunoassay. Correlation with vertical transmission of hepatitis B virus in Taiwan.  J Med Virol . 1979;  3 237-241
    PubMedSuche in Google Scholar
  • 57 Alter M J, Margolis H S. The emergence of hepatitis B as a sexually transmitted disease.  Med Clin North Am . 1990;  74 1529-1541
    PubMedSuche in Google Scholar
  • 58 Centers for Disease Control. Lack of transmission of hepatitis B to humans after oral exposure to hepatitis B surface antigen-positive saliva.  Morbidity and Mortality Weekly Report . 1978;  27 247-248
    PubMedSuche in Google Scholar
  • 59 Glaser J B, Nadler J P. Hepatitis B virus in a cardiopulmonary resuscitation training course.  Arch Intern Med . 1985;  145 1653-1655
    CrossrefPubMedSuche in Google Scholar
  • 60 Xu Z Y, Liu C B, Francis D P. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized double-blind placebo-controlled and comparative trial.  Pediatrics . 1985;  76 713-718
    PubMedSuche in Google Scholar
  • 61 Beasley R P, Hwang L-Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers.  J Infect Dis . 1983;  147 185-190
    PubMedSuche in Google Scholar
  • 62 Franks A L, Berg C J, Kane M A. Hepatitis B infection among children born in the United States to Southeast Asian refugees.  N Engl J Med . 1989;  321 1301-1305
    PubMedSuche in Google Scholar
  • 63 Hurie M B, Mast E E, Davis J P. Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees.  Pediatrics . 1992;  89 269-273
    PubMedSuche in Google Scholar
  • 64 Toukan A U, Sharaiha Z K, Abu-el-rub O A. The epidemiology of hepatitis B virus among family members in the Middle East.  Am J Epidemiol . 1990;  132 220-232
    PubMedSuche in Google Scholar
  • 65 Pon E W, Ren H X, Margolis H S. Hepatitis B virus infection in Honolulu students.  Pediatrics . 1993;  92 574-578
    PubMedSuche in Google Scholar
  • 66 Bernier R H, Sampliner R, Gerety R. Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection.  Am J Epidemiol . 1982;  116 199-211
    PubMedSuche in Google Scholar
  • 67 Szmuness W, Harley E J, Prince A M. Intrafamilial spread of asymptomatic hepatitis B.  Am J Med Sci . 1975;  270 293-304
    PubMedSuche in Google Scholar
  • 68 Petersen N J, Barrett D H, Bond W H. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages.  Appl Environ Microbiol . 1976;  32 572-574
    PubMedSuche in Google Scholar
  • 69 Margolis H S, Alter M J, Hadler S C. Hepatitis B: evolving epidemiology and implications for control.  Semin Liver Dis . 1991;  11 84-92
    PubMedSuche in Google Scholar
  • 70 Margolis H S, Alter M J, Hadler S C. Viral hepatitis. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans, 4th ed New York: Plenum Medical Book 1997: 363-418
    Suche in Google Scholar
  • 71 Bogomolski-Yahalom V, Granot E, Linder N. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk.  J Med Virol . 1991;  34 217-222
    PubMedSuche in Google Scholar
  • 72 Germinario C, Lopalco P L, Chicanna M, Da Villa G. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience.  Vaccine . 2000;  18 S83-S85
    CrossrefPubMedSuche in Google Scholar
  • 73 Spada E, Mele A, Ciccozzi M. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy.  Dig Liver Dis . 2001;  33 778-784
    CrossrefPubMedSuche in Google Scholar
  • 74 Van Steenbergen E J, Niesters H GM, Op de Coul L M E. Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997.  J Med Virol . 2002;  66 159-165
    CrossrefPubMedSuche in Google Scholar
  • 75 Goldstein S T, Alter M J, Williams I T. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998; implications for vaccination programs.  J Infect Dis . 2002;  185 713-719
    CrossrefPubMedSuche in Google Scholar
  • 76 Connolly J H, McClelland W M, O'Neill H J, Crowley D. Hepatitis B virus infection in Northern Ireland 1970-1987.  Ulster Med J . 1989;  58 72-82
    PubMedSuche in Google Scholar
  • 77 Brabin B, Beeching N J, Bunn J EG. Hepatitis B prevalence among Somali households in Liverpool.  Arch Dis Child . 2002;  86 67-68
    CrossrefPubMedSuche in Google Scholar
  • 78 Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP).  Morbidity and Mortality Weekly Report . 1991;  40(RR-13) 1-25
    PubMedSuche in Google Scholar
  • 79 Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission in the United States.  Morbidity and Mortality Weekly Report . 1995;  44 574-575
    PubMedSuche in Google Scholar
  • 80 Healy C M, Cafferkey M T, Butler K M. Antenatal hepatitis B screening-is there a need for a national policy?.  Irish Med J . 2001;  94 111-112
    PubMedSuche in Google Scholar
  • 81 Van Steenbergen E J, Leentvaar-Kuijpers A, Baayen D. Evaluation of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998.  Vaccine . 2001;  20 7-11
    CrossrefPubMedSuche in Google Scholar
  • 82 Salleras L, Bruguera M, Vidal J. Prevalence of markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents.  Eur J Epidemiol . 1992;  8 640-644
    CrossrefPubMedSuche in Google Scholar
  • 83 Da Villa G. Rationale for the infant and adolescent vaccination programmes in Italy.  Vaccine . 2000;  18 S31-S34
    CrossrefPubMedSuche in Google Scholar
  • 84 Magdzik W. Hepatitis B epidemiology in Poland, Central and Eastern Europe and the newly independent states.  Vaccine . 2000;  18 S13-S16
    CrossrefPubMedSuche in Google Scholar
  • 85 Popa I M, Pistol A, Mast E E. Use of surveillance for acute hepatitis among children to assess the impact of routine infant hepatitis B vaccination programs in Romania. In: Margolis HS, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease Atlanta: International Medical Press 2002: 261-262
    Suche in Google Scholar
  • 86 Ni Y-H, Chang M-H, Huang L-M. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination.  Ann Intern Med . 2001;  135 796-800
    PubMedSuche in Google Scholar
  • 87 Chang M H, Chen C J, Lai M S. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.  N Engl J Med . 1997;  336 1855-1859
    CrossrefPubMedSuche in Google Scholar
  • 88 Da Villa G , Sepe A , Piccinino F , Scolastico c . Pilot project of universal hepatitis B vaccination of newborns in a hyperendemic area: results after 17 years. In: Margolis HS, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease. Atlanta: International Medical Press 2002: 258-260
    Suche in Google Scholar
  • 89 Armstrong G L, Mast E E, Wojczynski M, Margolis H S. Childhood hepatitis B virus infections in the United States before hepatitis B immunization.  Pediatrics . 2001;  108 1123-1128
    CrossrefPubMedSuche in Google Scholar
  • 90 Centers for Disease Control. Current trends in hepatitis B virus vaccine safety: report of an inter-agency group.  MMWR . 1982;  31 465-467
    PubMedSuche in Google Scholar
  • 91 Centers for Disease Control. Hepatitis B vaccine: evidence confirming lack of AIDS transmission.  MMWR . 1984;  33 685-687
    PubMedSuche in Google Scholar
  • 92 Grotto I, Mandel Y, Ephros M, Ashkenazi I, Shemer J. Major adverse reactions to yeast-derived hepatitis B vaccines-a review.  Vaccine . 1998;  16 329-324
    CrossrefPubMedSuche in Google Scholar
  • 93 Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S. Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis.  N Engl J Med . 2001;  344 319-326
    CrossrefPubMedSuche in Google Scholar
  • 94 Ascherio A, Zhang S M, Hernán M A. Hepatitis B vaccination and the risk of multiple sclerosis.  N Engl J Med . 2001;  344 327-332
    CrossrefPubMedSuche in Google Scholar
  • 95 Institute of Medicine Immunization Safety Review Committee. In: Stratton K, Almario D, McCormick MC, eds. Hepatitis B Vaccine and Demyelinating Disorders, Washington, DC: National Academy Press 2002: 1-106
    Suche in Google Scholar
  • 96 Francois G, Kew M, Van Damme P, Mphahlele M J, Meheus A. Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?.  Vaccine . 2001;  19 3799-3815
    CrossrefPubMedSuche in Google Scholar
  • 97 Hsu H-Y, Chang M-H, Liaw S-H, Ni Y-H, Chen H-L. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan.  Hepatology . 1999;  30 1312-1317
    CrossrefPubMedSuche in Google Scholar
  • 98 Nainan O V, Khristova M L, Byun K-S. Frequency and significance of hepatitis B virus antibody resistant mutants (Abst).  Antiviral Ther . 2000;  5(Suppl) 29-30
    PubMedSuche in Google Scholar
  • 99 Ogata N, Cote P J, Zanetti A R. Licensed recombinant hepatitis B vaccine protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.  Hepatology . 1999;  30 779-786
    CrossrefPubMedSuche in Google Scholar